• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎严重程度分级

Grading of the severity of atopic dermatitis.

作者信息

Rajka G, Langeland T

机构信息

Department of Dermatology, National Hospital, Rikshospitalet, Oslo, Norway.

出版信息

Acta Derm Venereol Suppl (Stockh). 1989;144:13-4. doi: 10.2340/000155551441314.

DOI:10.2340/000155551441314
PMID:2800895
Abstract

A simple system for baseline grading the severity of atopic dermatitis in clinical work, is presented. The grading, which may be carried out on the basis of one single consultation, permits distinction between mild, moderate and severe atopic dermatitis by means of a score summation using the following parameters: 1) extent (by "rule of nine"), 2) course (via history) and 3) intensity (disturbance of night's sleep by itching).

摘要

本文介绍了一种在临床工作中对特应性皮炎严重程度进行基线分级的简单系统。该分级可在单次会诊的基础上进行,通过对以下参数进行评分求和,区分轻度、中度和重度特应性皮炎:1)范围(采用“九分法”),2)病程(通过病史),3)强度(瘙痒对夜间睡眠的干扰)。

相似文献

1
Grading of the severity of atopic dermatitis.特应性皮炎严重程度分级
Acta Derm Venereol Suppl (Stockh). 1989;144:13-4. doi: 10.2340/000155551441314.
2
The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.乳清与菟丝子提取物联合应用对成人中重度特应性皮炎的疗效:一项随机、双盲、安慰剂对照临床试验。
J Ethnopharmacol. 2015 Aug 22;172:325-32. doi: 10.1016/j.jep.2015.07.003. Epub 2015 Jul 4.
3
Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis.六区域、六体征特应性皮炎(SASSAD)严重程度评分:一种用于监测特应性皮炎疾病活动的简单系统。
Br J Dermatol. 1996 Sep;135 Suppl 48:25-30. doi: 10.1111/j.1365-2133.1996.tb00706.x.
4
What happens to the severity grading by objective SCORAD if we over- or underestimate disease extent or intensity in patients with atopic dermatitis?如果我们对特应性皮炎患者的疾病程度或强度过高或过低估计,那么客观 SCORAD 的严重程度分级会发生什么变化?
Int J Dermatol. 2012 Mar;51(3):295-9. doi: 10.1111/j.1365-4632.2011.05004.x.
5
Characteristics of Pruritus in Relation to Self-assessed Severity of Atopic Dermatitis.瘙痒特征与特应性皮炎自我评估严重程度的关系。
Acta Derm Venereol. 2019 Mar 1;99(3):279-283. doi: 10.2340/00015555-3053.
6
Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.特应性皮炎成人患者疾病控制不佳和疾病严重程度与患者报告疾病负担的相关性。
JAMA Dermatol. 2018 Aug 1;154(8):903-912. doi: 10.1001/jamadermatol.2018.1572.
7
Lesson from performing SCORADs in children with atopic dermatitis: subjective symptoms do not correlate well with disease extent or intensity.对特应性皮炎患儿进行SCORAD评估得出的经验:主观症状与疾病范围或严重程度的相关性不佳。
Int J Dermatol. 2006 Jun;45(6):728-30. doi: 10.1111/j.1365-4632.2005.02703.x.
8
Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis.特应性皮炎青少年和成人患者的湿疹面积和严重程度指数(EASI)、改良 EASI、特应性皮炎评分(SCORAD)、客观 SCORAD、特应性皮炎严重程度指数和体表面积严重程度分层。
Br J Dermatol. 2017 Nov;177(5):1316-1321. doi: 10.1111/bjd.15641. Epub 2017 Oct 1.
9
Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis.在特应性皮炎患者中,疾病的严重程度而非皮肤干燥与瘙痒相关。
Int J Dermatol. 2009 Apr;48(4):374-8. doi: 10.1111/j.1365-4632.2009.03906.x.
10
Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis.确定犬特应性皮炎严重程度增加时的CADESI-03阈值。
Vet Dermatol. 2008 Jun;19(3):115-9. doi: 10.1111/j.1365-3164.2008.00668.x.

引用本文的文献

1
Benralizumab Depletes IL-5Rα-Bearing Cells in Skin Lesions of Patients With Atopic Dermatitis.贝那利珠单抗可清除特应性皮炎患者皮肤病变中表达白细胞介素-5受体α的细胞。
Clin Transl Allergy. 2025 Aug;15(8):e70090. doi: 10.1002/clt2.70090.
2
Lack of association of atopic dermatitis severity and morphology with asthma onset and control.特应性皮炎严重程度和形态与哮喘发病和控制无关联。
Arch Dermatol Res. 2024 May 25;316(6):254. doi: 10.1007/s00403-024-03013-0.
3
Safety and efficacy of pimecrolimus versus vehicle for the treatment of atopic dermatitis in adults and paediatric population: a systematic review and meta-analysis.
吡美莫司与赋形剂治疗成人和儿童特应性皮炎的安全性和有效性:一项系统评价和荟萃分析。
Ann Med Surg (Lond). 2023 May 22;85(7):3563-3573. doi: 10.1097/MS9.0000000000000844. eCollection 2023 Jul.
4
A Nano-Emulsion Containing Ceramide-like Lipo-Amino Acid Cholesteryl Derivatives Improves Skin Symptoms in Patients with Atopic Dermatitis by Ameliorating the Water-Holding Function.一种含有神经酰胺样脂氨基酸胆固醇衍生物的纳米乳剂,通过改善皮肤保水功能改善特应性皮炎患者的皮肤症状。
Int J Mol Sci. 2022 Nov 1;23(21):13362. doi: 10.3390/ijms232113362.
5
Patient-reported outcome (PRO) instruments for disease severity and quality of life in patients with atopic dermatitis: a systematic review of English and Chinese literature.特应性皮炎患者疾病严重程度和生活质量的患者报告结局(PRO)工具:英文和中文文献的系统评价
Ann Transl Med. 2022 Aug;10(16):906. doi: 10.21037/atm-22-3164.
6
Factors associated with severity of atopic dermatitis - a Finnish cross-sectional study.与特应性皮炎严重程度相关的因素——一项芬兰横断面研究。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2130-2139. doi: 10.1111/jdv.18378. Epub 2022 Jul 22.
7
2019 Consensus Korean Diagnostic Guidelines to Define Severity Classification and Treatment Refractoriness for Atopic Dermatitis: Objective and Subjective Assessment of Severity.2019年韩国特应性皮炎严重程度分类及治疗难治性定义的共识诊断指南:严重程度的客观与主观评估
Ann Dermatol. 2019 Dec;31(6):654-661. doi: 10.5021/ad.2019.31.6.654. Epub 2019 Oct 31.
8
Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum.全基因组测序鉴定疱疹样湿疹患者的新基因突变。
Allergy. 2021 Aug;76(8):2510-2523. doi: 10.1111/all.14762. Epub 2021 Mar 15.
9
Lower influenza-specific cell-mediated immune responses in individuals with atopic dermatitis compared with healthy controls.与健康对照组相比,特应性皮炎患者的流感特异性细胞介导免疫反应较低。
Hum Vaccin Immunother. 2020 Nov 1;16(11):2727-2735. doi: 10.1080/21645515.2020.1747374. Epub 2020 Apr 29.
10
Enhancement of Chemokine mRNA Expression by Toll-Like Receptor 2 Stimulation in Human Peripheral Blood Mononuclear Cells of Patients with Atopic Dermatitis.变应性湿疹患者外周血单个核细胞中 Toll 样受体 2 刺激引起趋化因子 mRNA 表达增强。
Biomed Res Int. 2020 Mar 19;2020:1497175. doi: 10.1155/2020/1497175. eCollection 2020.